Impact of quercetin on systemic levels of inflammation: a meta-analysis of randomised controlled human trials

References

• Abbey EL, Rankin JW. 2011. Effect of quercetin supplementation on repeated-sprint performance, xanthine oxidase activity, and inflammation. Int J Sport Nutr Exerc Metab. 21(2):91–96.
   PubMed Web of Science ®Google Scholar
• Aldayel AM, O'Mary HL, Valdes SA, Li X, Thakkar SG, Mustafa BE, Cui Z. 2018. Lipid nanoparticles with minimum burst release of TNF-α siRNA show strong activity against rheumatoid arthritis unresponsive to methotrexate. J Control Rel. 283:280–289.
   PubMed Web of Science ®Google Scholar
• Armitage J. 2007. The safety of statins in clinical practice. Lancet. 370(9601):1781–1790.
   PubMed Web of Science ®Google Scholar
• Askari G, Ghiasvand R, Feizi A, Ghanadian SM, Karimian J. 2012. The effect of quercetin supplementation on selected markers of inflammation and oxidative stress. J Res Med Sci. 17(7):637–641.
   PubMed Web of Science ®Google Scholar
• Begg CB, Mazumdar M. 1994. Operating characteristics of a rank correlation test for publication bias. Biometrics. 50(4):1088–1101.
   PubMed Web of Science ®Google Scholar
• Brull V, Burak C, Stoffel-Wagner B, Wolffram S, Nickenig G, Muller C, Langguth P, Alteheld B, Fimmers R, Naaf S, et al. 2015. Effects of a quercetin-rich onion skin extract on 24 h ambulatory blood pressure and endothelial function in overweight-to-obese patients with (pre-)hypertension: a randomised double-blinded placebo-controlled cross-over trial. Br J Nutr. 114(8):1263–1277.
   PubMed Web of Science ®Google Scholar
• Brull V, Burak C, Stoffel-Wagner B, Wolffram S, Nickenig G, Muller C, Langguth P, Alteheld B, Fimmers R, Stehle P, et al. 2017. No effects of quercetin from onion skin extract on serum leptin and adiponectin concentrations in overweight-to-obese patients with (pre-)hypertension: a randomized double-blinded, placebo-controlled crossover trial. Eur J Nutr. 56(7):2265–2275.
   PubMed Web of Science ®Google Scholar
• Caria H, Chaveca T, Laires A, Rueff J. 1995. Genotoxicity of quercetin in the micronucleus assay in mouse bone marrow erythrocytes, human lymphocytes, V79 cell line and identification of kinetochore-containing (CREST staining) micronuclei in human lymphocytes. Mutat Res. 343(2–3):85–94.
   PubMed Web of Science ®Google Scholar
• Carstensen M, Herder C, Kivimaki M, Jokela M, Roden M, Shipley MJ, Witte DR, Brunner EJ, Tabak AG. 2010. Accelerated increase in serum interleukin-1 receptor antagonist starts 6 years before diagnosis of type 2 diabetes: Whitehall II prospective cohort study. Diabetes. 59(5):1222–1227.
   PubMed Web of Science ®Google Scholar
• Chekalina N, Burmak Y, Petrov Y, Borisova Z, Manusha Y, Kazakov Y, Kaidashev I. 2018. Quercetin reduces the transcriptional activity of NF-kB in stable coronary artery disease. Indian Heart J. 70(5):593–597.
   PubMedGoogle Scholar
• Chun OK, Chung SJ, Claycombe KJ, Song WO. 2008. Serum C-reactive protein concentrations are inversely associated with dietary flavonoid intake in U.S. adults. J Nutr. 138(4):753–760.
   PubMed Web of Science ®Google Scholar
• Cochrane Handbook. 2018. Cochrane handbook for systematic reviews of interventions version 5.1; [accessed 2018 Aug 20]. https://training.cochrane.org/handbook
   Google Scholar
• Combadiere C, Potteaux S, Rodero M, Simon T, Pezard A, Esposito B, Merval R, Proudfoot A, Tedgui A, Mallat Z. 2008. Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice. Circulation. 117(13):1649–1657.
   PubMed Web of Science ®Google Scholar
• Dower JI, Geleijnse JM, Gijsbers L, Schalkwijk C, Kromhout D, Hollman PC. 2015. Supplementation of the pure flavonoids epicatechin and quercetin affects some biomarkers of endothelial dysfunction and inflammation in (pre)hypertensive adults: a randomized double-blind, placebo-controlled, crossover trial. J Nutr. 145(7):1459–1463.
   PubMed Web of Science ®Google Scholar
• Egert S, Boesch-Saadatmandi C, Wolffram S, Rimbach G, Muller MJ. 2010. Serum lipid and blood pressure responses to quercetin vary in overweight patients by apolipoprotein E genotype. J Nutr. 140(2):278–284.
   PubMed Web of Science ®Google Scholar
• Egert S, Bosy-Westphal A, Seiberl J, Kurbitz C, Settler U, Plachta-Danielzik S, Wagner AE, Frank J, Schrezenmeir J, Rimbach G, et al. 2009. Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study. Br J Nutr. 102(7):1065–1074.
   PubMed Web of Science ®Google Scholar
• Egger M, Davey SG, Schneider M, Minder C. 1997. Bias in meta-analysis detected by a simple, graphical test. BMJ. 315(7109):629–634.
   PubMed Web of Science ®Google Scholar
• Endale M, Park SC, Kim S, Kim SH, Yang Y, Cho JY, Rhee MH. 2013. Quercetin disrupts tyrosine-phosphorylated phosphatidylinositol 3-kinase and myeloid differentiation factor-88 association, and inhibits MAPK/AP-1 and IKK/NF-κB-induced inflammatory mediators production in RAW 264.7 cells. Immunobiology. 218(12):1452–1467.
   PubMed Web of Science ®Google Scholar
• Farkas O, Jakus J, Heberger K. 2004. Quantitative structure–antioxidant activity relationships of flavonoid compounds. Molecules. 9(12):1079–1088.
   PubMed Web of Science ®Google Scholar
• Francois RJ, Neure L, Sieper J, Braun J. 2006. Immunohistological examination of open sacroiliac biopsies of patients with ankylosing spondylitis: detection of tumour necrosis factor alpha in two patients with early disease and transforming growth factor beta in three more advanced cases. Ann Rheum Dis. 65(6):713–720.
   PubMed Web of Science ®Google Scholar
• Frink M, van Griensven M, Kobbe P, Brin T, Zeckey C, Vaske B, Krettek C, Hildebrand F. 2009. IL-6 predicts organ dysfunction and mortality in patients with multiple injuries. Scand J Trauma Resus. 17:49.
   PubMed Web of Science ®Google Scholar
• Garcia-Mediavilla V, Crespo I, Collado PS, Esteller A, Sanchez-Campos S, Tunon MJ, Gonzalez-Gallego J. 2007. The anti-inflammatory flavones quercetin and kaempferol cause inhibition of inducible nitric oxide synthase, cyclooxygenase-2 and reactive C-protein, and down-regulation of the nuclear factor kappaB pathway in Chang Liver cells. Eur J Pharmacol. 557:221–229.
   PubMed Web of Science ®Google Scholar
• Grosso G, Godos J, Lamuela-Raventos R, Ray S, Micek A, Pajak A, Sciacca S, D'Orazio N, Del RD, Galvano F. 2017. A comprehensive meta-analysis on dietary flavonoid and lignan intake and cancer risk: level of evidence and limitations. Mol Nutr Food Res. 61.
   PubMed Web of Science ®Google Scholar
• Guo X, Zhang D, Gao X, Parry J, Liu K, Liu B, Wang M. 2013. Quercetin and quercetin-3-O-glucuronide are equally effective in ameliorating endothelial insulin resistance through inhibition of reactive oxygen species-associated inflammation. Mol Nutr Food Res. 57(6):1037–1045.
   PubMed Web of Science ®Google Scholar
• Hansson GK. 2005. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 352(16):1685–1695.
   PubMed Web of Science ®Google Scholar
• Harwood M, Danielewska-Nikiel B, Borzelleca JF, Flamm GW, Williams GM, Lines TC. 2007. A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties. Food Chem Toxicol. 45(11):2179–2205.
   PubMed Web of Science ®Google Scholar
• Heim KE, Tagliaferro AR, Bobilya DJ. 2002. Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships. J Nutr Biochem. 13(10):572–584.
   PubMed Web of Science ®Google Scholar
• Heinz SA, Henson DA, Nieman DC, Austin MD, Jin F. 2010. A 12-week supplementation with quercetin does not affect natural killer cell activity, granulocyte oxidative burst activity or granulocyte phagocytosis in female human subjects. Br J Nutr. 104(6):849–857.
   PubMed Web of Science ®Google Scholar
• Higgins JPT, Altman DG, Gotzsche PC, Jueni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne J. 2011. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 343:d5928.
   PubMed Web of Science ®Google Scholar
• Higuchi Y, McTiernan CF, Frye CB, McGowan BS, Chan TO, Feldman AM. 2004. Tumor necrosis factor receptors 1 and 2 differentially regulate survival, cardiac dysfunction, and remodeling in transgenic mice with tumor necrosis factor-alpha-induced cardiomyopathy. Circulation. 109(15):1892–1897.
   PubMed Web of Science ®Google Scholar
• Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ. 1996. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 17(1):1–12.
   PubMedGoogle Scholar
• Javadi F, Ahmadzadeh A, Eghtesadi S, Aryaeian N, Zabihiyeganeh M, Rahimi FA, Jazayeri S. 2017. The effect of quercetin on inflammatory factors and clinical symptoms in women with rheumatoid arthritis: a double-blind, randomized controlled trial. J Am Coll Nutr. 36(1):9–15.
   PubMed Web of Science ®Google Scholar
• Javadi F, Eghtesadi S, Ahmadzadeh A, Aryaeian N, Zabihiyeganeh M, Foroushani AR, Jazayeri S. 2014. The effect of quercetin on plasma oxidative status, C-reactive protein and blood pressure in women with rheumatoid arthritis. Int J Prev Med. 5(3):293–301.
   PubMedGoogle Scholar
• Kleemann R, Verschuren L, Morrison M, Zadelaar S, van Erk MJ, Wielinga PY, Kooistra T. 2011. Anti-inflammatory, anti-proliferative and anti-atherosclerotic effects of quercetin in human in vitro and in vivo models. Atherosclerosis. 218(1):44–52.
   PubMed Web of Science ®Google Scholar
• Knab AM, Shanely RA, Henson DA, Jin F, Heinz SA, Austin MD, Nieman DC. 2011. Influence of quercetin supplementation on disease risk factors in community-dwelling adults. J Am Diet Assoc. 111(4):542–549.
   PubMed Web of Science ®Google Scholar
• Lee KH, Park E, Lee HJ, Kim MO, Cha YJ, Kim JM, Lee H, Shin MJ. 2011. Effects of daily quercetin-rich supplementation on cardiometabolic risks in male smokers. Nutr Res Pract. 5(1):28–33.
   PubMed Web of Science ®Google Scholar
• Li Y, Yao J, Han C, Yang J, Chaudhry MT, Wang S, Liu H, Yin Y. 2016. Quercetin, inflammation and immunity. Nutrients. 8(3):167.
   PubMed Web of Science ®Google Scholar
• Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. 2009. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 62(10):e1–e34.
   PubMed Web of Science ®Google Scholar
• Lin W, Wang W, Yang H, Wang D, Ling W. 2016. Influence of intestinal microbiota on the catabolism of flavonoids in mice. J Food Sci. 81(12):H3026–H3034.
   PubMed Web of Science ®Google Scholar
• Ma YK, Chen YB, Li P. 2018. Quercetin inhibits NTHi-triggered CXCR4 activation through suppressing IKKα/NF-κB and MAPK signaling pathways in otitis media. Int J Mol Med. 42(1):248–258.
   PubMed Web of Science ®Google Scholar
• Marcolin E, San-Miguel B, Vallejo D, Tieppo J, Marroni N, Gonzalez-Gallego J, Tunon MJ. 2012. Quercetin treatment ameliorates inflammation and fibrosis in mice with nonalcoholic steatohepatitis. J Nutr. 142(10):1821–1828.
   PubMed Web of Science ®Google Scholar
• Mohammadi-Sartang M, Mazloom Z, Sherafatmanesh S, Ghorbani M, Firoozi D. 2017. Effects of supplementation with quercetin on plasma C-reactive protein concentrations: a systematic review and meta-analysis of randomized controlled trials. Eur J Clin Nutr. 71(9):1033–1039.
   PubMed Web of Science ®Google Scholar
• NTP. 1992. Toxicology and carcinogenesis studies of quercetin (CAS no. 117-39-5) in F344 rats (feed studies). Natl Toxicol Program Tech Rep Ser. 409:1–171.
   PubMedGoogle Scholar
• Nurmi T, Mursu J, Heinonen M, Nurmi A, Hiltunen R, Voutilainen S. 2009. Metabolism of berry anthocyanins to phenolic acids in humans. J Agric Food Chem. 57(6):2274–2281.
   PubMed Web of Science ®Google Scholar
• Nurnberger W, Platonov A, Stannigel H, Beloborodov VB, Michelmann I, von Kries R, Burdach S, Gobel U. 1995. Definition of a new score for severity of generalized Neisseria meningitidis infection. Eur J Pediatr. 154(11):896–900.
   PubMed Web of Science ®Google Scholar
• O'Fallon KS, Kaushik D, Michniak-Kohn B, Dunne CP, Zambraski EJ, Clarkson PM. 2012. Effects of quercetin supplementation on markers of muscle damage and inflammation after eccentric exercise. Int J Sport Nutr Exerc Metab. 22(6):430–437.
   PubMed Web of Science ®Google Scholar
• Park HJ, Lee CM, Jung ID, Lee JS, Jeong YI, Chang JH, Chun SH, Kim MJ, Choi IW, Ahn SC, et al. 2009. Quercetin regulates Th1/Th2 balance in a murine model of asthma. Int Immunopharmacol. 9(3):261–267.
   PubMed Web of Science ®Google Scholar
• Patsopoulos NA, Evangelou E, Ioannidis JP. 2008. Sensitivity of between-study heterogeneity in meta-analysis: proposed metrics and empirical evaluation. Int J Epidemiol. 37(5):1148–1157.
   PubMed Web of Science ®Google Scholar
• Peng X, Zhang Z, Zhang N, Liu L, Li S, Wei H. 2014. In vitro catabolism of quercetin by human fecal bacteria and the antioxidant capacity of its catabolites. Food Nutr Res. 58:62–74.
   Web of Science ®Google Scholar
• Perez-Vizcaino F, Duarte J, Santos-Buelga C. 2012. The flavonoid paradox: conjugation and deconjugation as key steps for the biological activity of flavonoids. J Sci Food Agric. 92(9):1822–1825.
   PubMed Web of Science ®Google Scholar
• Pfeuffer M, Auinger A, Bley U, Kraus-Stojanowic I, Laue C, Winkler P, Rufer CE, Frank J, Bosch-Saadatmandi C, Rimbach G, et al. 2013. Effect of quercetin on traits of the metabolic syndrome, endothelial function and inflammation in men with different APOE isoforms. Nutr Metab Cardiovasc Dis. 23(5):403–409.
   PubMed Web of Science ®Google Scholar
• Ridker PM, MacFadyen JG, Glynn RJ, Koenig W, Libby P, Everett BM, Lefkowitz M, Thuren T, Cornel JH. 2018. Inhibition of interleukin-1β by canakinumab and cardiovascular outcomes in patients with chronic kidney disease. J Am Coll Cardiol. 71(21):2405–2414.
   PubMed Web of Science ®Google Scholar
• Sekhon-Loodu S, Catalli A, Kulka M, Wang Y, Shahidi F, Rupasinghe HP. 2014. Apple flavonols and n-3 polyunsaturated fatty acid-rich fish oil lowers blood C-reactive protein in rats with hypercholesterolemia and acute inflammation. Nutr Res. 34(6):535–543.
   PubMed Web of Science ®Google Scholar
• Serban MC, Sahebkar A, Zanchetti A, Mikhailidis DP, Howard G, Antal D, Andrica F, Ahmed A, Aronow WS, Muntner P, et al. 2016. Effects of quercetin on blood pressure: a systematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc. 5:pii: e002713.
   Web of Science ®Google Scholar
• Shoskes DA, Zeitlin SI, Shahed A, Rajfer J. 1999. Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial. Urology. 54(6):960–963.
   PubMed Web of Science ®Google Scholar
• Singh-Manoux A, Shipley MJ, Bell JA, Canonico M, Elbaz A, Kivimaki M. 2017. Association between inflammatory biomarkers and all-cause, cardiovascular and cancer-related mortality. CMAJ. 189(10):E384–E390.
   PubMed Web of Science ®Google Scholar
• Solinas G, Karin M. 2010. JNK1 and IKKbeta: molecular links between obesity and metabolic dysfunction. FASEB J. 24(8):2596–2611.
   PubMed Web of Science ®Google Scholar
• Solomon SD, Wittes J, Finn PV, Fowler R, Viner J, Bertagnolli MM, Arber N, Levin B, Meinert CL, Martin B, et al. 2008. Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: the cross trial safety analysis. Circulation. 117(16):2104–2113.
   PubMed Web of Science ®Google Scholar
• Toussi SS, Pan N, Walters HM, Walsh TJ. 2013. Infections in children and adolescents with juvenile idiopathic arthritis and inflammatory bowel disease treated with tumor necrosis factor-α inhibitors: systematic review of the literature. Clin Infect Dis. 57(9):1318–1330.
   PubMed Web of Science ®Google Scholar
• Um MY, Hwang KH, Choi WH, Ahn J, Jung CH, Ha TY. 2014. Curcumin attenuates adhesion molecules and matrix metalloproteinase expression in hypercholesterolemic rabbits. Nutr Res. 34(10):886–893.
   PubMed Web of Science ®Google Scholar
• Vazquez PM, Bettaieb A, Rodriguez LC, Soto VC, Perdicaro DJ, Galmarini CR, Haj FG, Miatello RM, Oteiza PI. 2015. Catechin and quercetin attenuate adipose inflammation in fructose-fed rats and 3T3-L1 adipocytes. Mol Nutr Food Res. 59:622–633.
   PubMed Web of Science ®Google Scholar
• Wang X, Ouyang YY, Liu J, Zhao G. 2014. Flavonoid intake and risk of CVD: a systematic review and meta-analysis of prospective cohort studies. Br J Nutr. 111(1):1–11.
   PubMed Web of Science ®Google Scholar
• Wang XF, Song SD, Li YJ, Hu ZQ, Zhang ZW, Yan CG, Li ZG, Tang HF. 2018. Protective effect of quercetin in LPS-induced murine acute lung injury mediated by cAMP–Epac pathway. Inflammation. 41(3):1093–1103.
   PubMed Web of Science ®Google Scholar
• Wianowska D, Dawidowicz AL. 2016. Effect of water content in extraction mixture on the pressurized liquid extraction efficiency-stability of quercetin 4′-glucoside during extraction from onions. J AOAC Int. 99(3):744.
   Web of Science ®Google Scholar
• Xiao J, Hogger P. 2015. Stability of dietary polyphenols under the cell culture conditions: avoiding erroneous conclusions. J Agric Food Chem. 63(5):1547–1557.
   PubMed Web of Science ®Google Scholar
• Xu H, Luo J, Huang J, Wen Q. 2018. Flavonoids intake and risk of type 2 diabetes mellitus: a meta-analysis of prospective cohort studies. Medicine. 97:e686.
   PubMed Web of Science ®Google Scholar
• Yang J, Kim CS, Tu TH, Kim MS, Goto T, Kawada T, Choi MS, Park T, Sung MK, Yun JW, et al. 2017. Quercetin protects obesity-induced hypothalamic inflammation by reducing microglia-mediated inflammatory responses via HO-1 induction. Nutrients. 9:pii: E650.
   Web of Science ®Google Scholar
• Zahedi M, Ghiasvand R, Feizi A, Asgari G, Darvish L. 2013. Does quercetin improve cardiovascular risk factors and inflammatory biomarkers in women with type 2 diabetes: a double-blind randomized controlled clinical trial. Int J Prev Med. 4(7):777–785.
   PubMedGoogle Scholar
• Zhao L, Cen F, Tian F, Li MJ, Zhang Q, Shen HY, Shen XC, Zhou MM, Du J. 2017. Combination treatment with quercetin and resveratrol attenuates high fat diet-induced obesity and associated inflammation in rats via the AMPKα1/SIRT1 signaling pathway. Exp Ther Med. 14(6):5942–5948.
   PubMed Web of Science ®Google Scholar